Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (81-90 of 241) with videos related to

Pageof 25
Sort By:
Breast Cancer (Tokyo, Japan)|May 2, 2025
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastYuko Takano, Kazuyuki Mizuno, Madoka Iwase, et al.
Cancer Science|March 8, 2026
FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database StudyKazuyuki Mizuno, Takuya Ishikawa, Takanori Ito, et al.
Journal of Geriatric Oncology|November 10, 2022
A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in JapanAyumu Matsuoka, Taichi Shimazu, Masahiro Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 22, 2022
Reduced masticatory performance and not using dentures are associated with hypertension in older adults with tooth loss: the Shimane CoHRE studyTakafumi Abe, Kazumichi Tominaga, Yuichi Ando, et al.
Surgery Today|August 15, 2013
Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancerYuichiro Yoshioka, Keisuke Uehara, Tomoki Ebata, et al.
Japanese Journal of Clinical Oncology|February 12, 2015
A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancerToru Nakanishi, Daisuke Aoki, Yoh Watanabe, et al.
Journal of Clinical Pharmacology|October 1, 2003
Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studiesMichelle A Rudek, Jürgen Venitz, Yuichi Ando, et al.
Cancer Biology & Therapy|March 19, 2003
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomideYuichi Ando, Douglas K Price, William L Dahut, et al.
Critical Reviews in Oncology/Hematology|July 10, 2003
Current status of thalidomide and its role in the treatment of metastatic prostate cancerGordon R Macpherson, Michael Franks, Andrada Tomoaia-Cotisel, et al.
BMC Oral Health|January 9, 2026
Sex differences in the association between tooth loss and socioeconomic status: the 8020 Promotion Foundation Study of Japanese Dental PatientsMizuki Saito, Yoshihiro Shimazaki, Kakuhiro Fukai, et al.
Pageof 25

Showing results (81-90 of 241) with videos related to

Sort By:
Pageof 25
Breast Cancer (Tokyo, Japan)|May 2, 2025
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastYuko Takano, Kazuyuki Mizuno, Madoka Iwase, et al.
Cancer Science|March 8, 2026
FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database StudyKazuyuki Mizuno, Takuya Ishikawa, Takanori Ito, et al.
Journal of Geriatric Oncology|November 10, 2022
A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in JapanAyumu Matsuoka, Taichi Shimazu, Masahiro Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 22, 2022
Reduced masticatory performance and not using dentures are associated with hypertension in older adults with tooth loss: the Shimane CoHRE studyTakafumi Abe, Kazumichi Tominaga, Yuichi Ando, et al.
Surgery Today|August 15, 2013
Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancerYuichiro Yoshioka, Keisuke Uehara, Tomoki Ebata, et al.
Japanese Journal of Clinical Oncology|February 12, 2015
A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancerToru Nakanishi, Daisuke Aoki, Yoh Watanabe, et al.
Journal of Clinical Pharmacology|October 1, 2003
Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studiesMichelle A Rudek, Jürgen Venitz, Yuichi Ando, et al.
Cancer Biology & Therapy|March 19, 2003
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomideYuichi Ando, Douglas K Price, William L Dahut, et al.
Critical Reviews in Oncology/Hematology|July 10, 2003
Current status of thalidomide and its role in the treatment of metastatic prostate cancerGordon R Macpherson, Michael Franks, Andrada Tomoaia-Cotisel, et al.
BMC Oral Health|January 9, 2026
Sex differences in the association between tooth loss and socioeconomic status: the 8020 Promotion Foundation Study of Japanese Dental PatientsMizuki Saito, Yoshihiro Shimazaki, Kakuhiro Fukai, et al.
Pageof 25